Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.2bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥8.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥4.1bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥373m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥425m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥370m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥486m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥409m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥362m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥341m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥258m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥143m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥214m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥258m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥214m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥11.5bnat 2022-09-30Cons.Assets
Total assets¥11.8bnat 2022-03-31Cons.Assets
Total assets¥12.4bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥8.2bnat 2022-09-30Cons.Liabilities
Total liabilities¥8.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥3.3bnat 2022-09-30Cons.Net assets
Net assets / equity¥3.1bnat 2022-03-31Cons.Net assets
Net assets / equity¥3.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥1.8bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥1.9bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥1.5bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥1.5bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥406m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥778m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥24m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥152m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥35m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥516m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥803m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥599m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥203.312022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.52022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-112.562021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥168.332021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.152021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio28.8%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio26.2%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.0%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥230m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30−¥55m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.6bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2022-04-01 → 2022-09-30¥601m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2022-04-01 → 2022-09-30¥194m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2022-04-01 → 2022-09-30¥11m
—segment totalrevenue2022-04-01 → 2022-09-30¥4.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥4.2bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥603m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥232m
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E01109-000Medical Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30−¥24m
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue2021-04-01 → 2021-09-30¥2.7bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.7bn
jpcrp040300-q2r_E01109-000Precision Equipmentreportable segmentsegment profit2021-04-01 → 2021-09-30¥671m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue2021-04-01 → 2021-09-30¥168m
jpcrp040300-q2r_E01109-000SPreportable segmentrevenue external2021-04-01 → 2021-09-30¥168m
jpcrp040300-q2r_E01109-000SPreportable segmentsegment profit2021-04-01 → 2021-09-30−¥5m
—segment totalrevenue2021-04-01 → 2021-09-30¥4.1bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥4.1bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥657m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 499
ItemContextValueUnit
Other nclPrior1YearInstant635381000JPY
Other nclCurrentQuarterInstant541747000JPY
Noncurrent liabilitiesPrior1YearInstant3034823000JPY
Noncurrent liabilitiesCurrentQuarterInstant2795752000JPY
LiabilitiesPrior1YearInstant8709191000JPY
LiabilitiesCurrentQuarterInstant8202225000JPY
Capital stockPrior1YearInstant643099000JPY
Capital stockCurrentQuarterInstant643099000JPY
Capital surplusPrior1YearInstant248362000JPY
Capital surplusCurrentQuarterInstant248362000JPY
Retained earningsPrior1YearInstant1852738000JPY
Retained earningsCurrentQuarterInstant2047193000JPY
Treasury stockPrior1YearInstant-39921000JPY
Treasury stockCurrentQuarterInstant-40319000JPY
Shareholders equityPrior1YearInstant2704280000JPY
Shareholders equityCurrentQuarterInstant2898336000JPY
Valuation difference on available for sale securitiesPrior1YearInstant75972000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant88964000JPY
Revaluation reserve for landPrior1YearInstant288295000JPY
Revaluation reserve for landCurrentQuarterInstant288295000JPY
Foreign currency translation adjustmentPrior1YearInstant20204000JPY
Foreign currency translation adjustmentCurrentQuarterInstant36232000JPY
Remeasurements of defined benefit plansPrior1YearInstant9666000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant8376000JPY
Valuation and translation adjustmentsPrior1YearInstant394138000JPY
Valuation and translation adjustmentsCurrentQuarterInstant421869000JPY
Net assetsPrior1YearInstant3098418000JPY
Net assetsCurrentQuarterInstant3320206000JPY
Liabilities and net assetsPrior1YearInstant11807610000JPY
Liabilities and net assetsCurrentQuarterInstant11522431000JPY
Net salesPrior1YTDDuration4112237000JPY
Net salesCurrentYTDDuration4171072000JPY
Cost of salesPrior1YTDDuration3023722000JPY
Cost of salesCurrentYTDDuration3158552000JPY
Gross profitPrior1YTDDuration1088514000JPY
Gross profitCurrentYTDDuration1012519000JPY
Selling general and administrative expensesPrior1YTDDuration663339000JPY
Selling general and administrative expensesCurrentYTDDuration639066000JPY
Operating incomePrior1YTDDuration425174000JPY
Operating incomeCurrentYTDDuration373453000JPY
Interest income noiPrior1YTDDuration159000JPY
Interest income noiCurrentYTDDuration7000JPY
Dividends income noiPrior1YTDDuration4157000JPY
Dividends income noiCurrentYTDDuration4966000JPY
Rent income noiPrior1YTDDuration6124000JPY
Rent income noiCurrentYTDDuration6798000JPY
Foreign exchange gains noiPrior1YTDDuration-JPY
Foreign exchange gains noiCurrentYTDDuration4527000JPY
Subsidy income noiPrior1YTDDuration17830000JPY
Subsidy income noiCurrentYTDDuration17270000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass